It is our pleasure to announce the release of the RePORT International Cross-Consortium RFP. The document is attached, with URL links to the forms and other documents needed for the submission.
Project duration is up to two years, with a commitment of $1 million USD (total costs) over two years to fund up to 3 projects.
Scope of Work should i) address clinical, socio-epidemiologic, biomarkers, and immune mechanisms predictive of the presence of or progression to TB including MDR-TB or adverse outcomes across Brazil, China, India, Indonesia, the Philippines, and South Africa, and; ii) utilize existing Common Protocol (or site protocol) data and/or biological samples or collect novel data and biologic specimens; iii) assess impact of co-conditions (COVID-19, diabetes mellitus, HIV, malnutrition, pregnancy) on TB.
The submission deadline is 22 February 2021 – with documents submitted to Daphne Martin at firstname.lastname@example.org
TB-RICC will administer the review, with an independent panel convened for scientific review, and decision and announcement in early April. CRDF Global will administer the awards and post-award management.
We look forward to receiving as many proposals!
Kindly write to us if you have any questions.